Method for preparing chitosan or sodium alginate-modified carbon nanotube-targeted slow release carrier
A technology of sodium alginate and slow-release carrier, which is applied in the field of preparation of nano-medicine technology, can solve the problems of non-targeting and high toxicity of carbon nanotube carriers, and achieves simple and easy preparation methods, good water solubility, Controllable Effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1. Single-walled carbon nanotubes (SWCNTs) prepared by chemical vapor deposition are used as the initial raw material. After acidification and truncation, chitosan or sodium alginate and folic acid are functionalized by non-covalent physical coating to the surface of single-walled carbon nanotubes, and adopt doxorubicin (DOX) as a model drug to obtain folic acid-targeted chitosan or sodium alginate-modified single-walled carbon nanotubes doxorubicin-targeted drug carrier, the specific steps are as follows :
[0031] Step (a): In 300 mL of 98% H with a volume ratio of 3:1 2 SO 4 and 65% HNO 3 Add 500 mg of single-walled carbon nanotube raw material to the mixed acid, sonicate for 24 hours in an ice-water bath at 0°C, filter with polytetrafluoroethylene microporous membrane with a pore size of Φ0.22 μm, and wash repeatedly with a large amount of deionized water until neutral, 50 After vacuum drying at ℃ for 24 hours, truncated single-walled carbon nanotubes wer...
Embodiment 2
[0039] Example 2, the single-walled carbon nanotubes (SWCNTs) prepared by chemical vapor deposition method are used as the initial raw material, and after acidification and truncation, chitosan or sodium alginate and folic acid are functionalized by non-covalent physical coating Go to the surface of single-walled carbon nanotubes, and use epirubicin (EPB) as a model drug to obtain folic acid-targeted chitosan or sodium alginate-modified single-walled carbon nanotubes doxorubicin-targeted drug carrier, specific steps as follows:
[0040] Step (a): In 300 mL of 98% H with a volume ratio of 3:1 2 SO 4 and 65% HNO 3 Add 500 mg of single-walled carbon nanotube raw material to the mixed acid, sonicate for 24 hours in an ice-water bath at 0°C, filter with polytetrafluoroethylene microporous membrane with a pore size of Φ0.22 μm, and wash repeatedly with a large amount of deionized water until neutral, 50 After vacuum drying at ℃ for 24 hours, truncated single-walled carbon nanotub...
Embodiment 3
[0045] Example 3, the multi-walled carbon nanotubes (MWCNTs) prepared by chemical vapor deposition method are used as the initial raw material, and after being shortened by acidification, chitosan or sodium alginate and folic acid are functionalized by non-covalent physical coating to the surface of multi-walled carbon nanotubes, and adopt doxorubicin (DOX) as a model drug to obtain folic acid-targeted chitosan or sodium alginate-modified multi-walled carbon nanotubes doxorubicin-targeted drug carrier, the specific steps are as follows :
[0046] Step (a): In 300 mL of 98% H with a volume ratio of 3:1 2 SO 4 and 65% HNO 3 Add 500 mg of multi-walled carbon nanotube raw material to the mixed acid, ultrasonicate for 24 hours in an ice-water bath at 0°C, filter with polytetrafluoroethylene microporous membrane with a pore size of Φ0.22 μm, and wash repeatedly with a large amount of deionized water until neutral, 50 After vacuum drying at ℃ for 24 hours, truncated multi-walled c...
PUM
Property | Measurement | Unit |
---|---|---|
Concentration | aaaaa | aaaaa |
Concentration | aaaaa | aaaaa |
Concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com